We just received data on a new analyst forecast for $VOR. An analyst from H.C. Wainwright set a price target of 3.0 for VOR.
To track analyst ratings and price targets for $VOR, check out Quiver Quantitative's $VOR forecast page.
$VOR Insider Trading Activity
$VOR insiders have traded $VOR stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $VOR stock by insiders over the last 6 months:
- EYAL C. ATTAR (CHIEF MEDICAL OFFICER) has made 0 purchases and 2 sales selling 4,781 shares for an estimated $6,661.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VOR Hedge Fund Activity
We have seen 18 institutional investors add shares of $VOR stock to their portfolio, and 34 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LYNX1 CAPITAL MANAGEMENT LP removed 637,218 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $457,203
- ENSIGN PEAK ADVISORS, INC removed 329,378 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $236,328
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 269,265 shares (+234.1%) to their portfolio in Q1 2025, for an estimated $193,197
- CITADEL ADVISORS LLC removed 200,405 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $143,790
- JANE STREET GROUP, LLC added 194,756 shares (+inf%) to their portfolio in Q1 2025, for an estimated $139,737
- RENAISSANCE TECHNOLOGIES LLC added 171,931 shares (+32.5%) to their portfolio in Q1 2025, for an estimated $123,360
- OMERS ADMINISTRATION CORP added 139,600 shares (+inf%) to their portfolio in Q1 2025, for an estimated $100,163
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
